| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ac2c17e532220d91aca9a28ef60f178b |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P23-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 |
| filingDate |
2014-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15f410f93eb59456f637750ec1b8f311
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b85343afb2da2a7fb75618e0e9f55a7a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa5e02e7cf0803c51fbcb797e3f6968c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_103bca972405f09e99e896bcb1f29652
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_649d5f57d43f04080b72d377bd82eec6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e144a596ee8e87a5860214174f4b5537
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9903c3675a1b7af983f92919a8b14fef |
| publicationDate |
2018-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20180016651-A |
| titleOfInvention |
Hydromorphone and naloxone for treatment of pain and opioid bowel dysfunction syndrome |
| abstract |
The present invention relates to a sustained release pharmaceutical dosage form comprising a hydro morphone or a pharmaceutically acceptable salt thereof and naloxone or a pharmaceutically acceptable salt thereof for use in the treatment of pain. |
| priorityDate |
2013-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |